From concept to consequence
MIT linQ programs are built on the principles of collaboration, learning by doing, and unrelenting focus on unmet needs.
Catalyst
Catalyst is pioneering a new method of research-driven biomedical innovation
An immersive, collaborative innovation program, Catalyst focuses on intensive, extended hands-on research and development, complemented by advanced technical and innovation training. Catalyst teams identify medical needs that can be met with innovative technologies, build multiprofessional teams to design these new technologies, and launch projects that show strong potential for healthcare impact.
Learn more
Catalyzing innovation
neuroQWERTY: Quantifying motor impairment
The motor signs of Parkinson’s disease and some other neurodegenerative conditions are subtle and difficult to diagnose objectively, especially early in the disease process when interventions may be more effective. Team neuroQWERTY realized that the solution for detecting this early decline may be literally at our fingertips—in daily interactions with computers, mobile phones, and tablets. Their technology can distinguish changes due to motor impairment from these keyboard tactile interactions.
Catalyzing innovation
Leuko: Noninvasive white blood cell monitoring improving safety and quality of life for chemotherapy patients.
PointCheck by Leuko Labs is a new technology spun out of the Catalyst program designed in response to the risks and challenges faced by chemotherapy patients. Instead of facing frequent and difficult blood draws, patients using PointCheck can quickly and painlessly check their white cell counts at home. Read more about Leuko
IDEA² Global
Mentorship and expertise for emerging innovators with an idea for a new technology.
